Home » Topics » BioWorld Science

BioWorld Science
RSS

New formulation of ciclosporin

Sep. 20, 1996

University of Kentucky's PC-16 for arthritis

Sep. 20, 1996

U.S. patent for herbal medication with potential in AIDS

Sep. 20, 1996

Canadian clearance for HIV protease inhibitor

Sep. 20, 1996

ACTG to evaluate 141W94/VX-478

Sep. 20, 1996

Expanded access program for HIV protease inhibitor

Sep. 20, 1996

AIDS treatment to enter clinical trials in Japan

Sep. 20, 1996

Anti-HIV compounds from Janssen

Sep. 20, 1996

Promising preliminary results with DMP-266

Sep. 20, 1996

New tablet formulation of valaciclovir

Sep. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...